Home > Income Statement > ALEMBIC

ALEMBIC
Revenue

    Back to Income Statement
ALEMBIC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ALEMBIC Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹222 Cr₹157 Cr₹127 Cr₹78 Cr₹74 Cr

What is the latest Revenue of ALEMBIC ?

The latest Revenue ratio of ALEMBIC is ₹222 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹222 Cr
Mar2024₹157 Cr
Mar2023₹127 Cr
Mar2022₹78 Cr
Mar2021₹74 Cr

How is Revenue of ALEMBIC Trending?

Years Revenue % Change
Mar2025 ₹222 Cr
40.89
Mar2024 ₹157 Cr
23.77
Mar2023 ₹127 Cr
62.68
Mar2022 ₹78 Cr
6.40
Mar2021 ₹74 Cr -

Compare Revenue of peers of ALEMBIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC ₹2,457.1 Cr -3.6% 0.7% -10% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,062.0 Cr 0.4% 2.6% NA Stock Analytics
DIVIS LABORATORIES ₹164,192.0 Cr -4.5% 0.7% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,129.0 Cr 5% 4.1% 37.2% Stock Analytics
CIPLA ₹108,513.0 Cr -0.5% -3.4% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,250.0 Cr 1.2% 10.2% 4.8% Stock Analytics


ALEMBIC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC

-3.6%

0.7%

-10%

SENSEX

-1%

-0.1%

7.9%


You may also like the below Video Courses